Press release
Key Influencer in the Non-Proliferative Diabetic Retinopathy Market 2025: Surging Prevalence Of Diabetes Fuels Growth In The Non-Proliferative Diabetic Retinopathy Market Driver
Non-Proliferative Diabetic Retinopathy Market Forecast
The market size for non-proliferative diabetic retinopathy has seen substantial growth in recent years. The projected growth is from $2.62 billion in 2024 to $2.84 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historic period is due to factors such as a rise in diabetes cases, an aging demographic, advancements in research, better understanding and management of diabetes, lifestyle modifications, and enhanced awareness.
The market size for non-proliferative diabetic retinopathy is predicted to experience robust growth in the coming years. The estimated projection for its expansion is $3.87 billion in 2029, with a compound annual growth rate (CAGR) of 8.0%. This anticipated growth over the forecast period can be linked to the increase of telemedicine, the rise in novel therapeutics, the use of artificial intelligence, a surge in R&D investments, and the broadening of healthcare infrastructure. Key trends for the forecast period incorporate the rising use of artificial intelligence for screening and diagnosis, growing demand for telemedicine and remote patient monitoring solutions, emergence of tailored medicine for treating diabetic retinopathy, increasing emphasis on prevention and early intervention strategies, and the expanding function of patient-focused care models in managing diabetic retinopathy.
What Factors Are Fueling Growth in the Non-Proliferative Diabetic Retinopathy Market?
The non-proliferative diabetic retinopathy market is projected to grow due to the rising prevalence of diabetes. Diabetes is a long-lasting metabolic disorder marked by high blood glucose levels, either due to the pancreas's insufficient insulin production or the body's cells' resistance to insulin. The illness can stem from sedentary lifestyles, poor eating habits, and genetic factors. Non-proliferative diabetic retinopathy, a common complication of diabetes, occurs when the retina's blood vessels are damaged, mainly due to prolonged elevated blood sugar levels. This can result in vision loss and potential blindness. For example, in June 2024, the UK's National Health Service reported that in 2023, an additional 549,000 people in England were identified as having a higher risk of developing type 2 diabetes. This finding increased the number of people registered with a General Practitioner for non-diabetic hyperglycemia, or pre-diabetes, to 3,615,330, showing a significant jump from 3,065,825 in 2022, approximately a rise of nearly 20%. Hence, the escalation in diabetes cases is fuelling the expansion of the non-proliferative diabetic retinopathy market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15620&type=smp
Which Businesses Are at the Forefront of Non-Proliferative Diabetic Retinopathy Market Development?
Major companies operating in the non-proliferative diabetic retinopathy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Genentech Inc., Carl Zeiss Meditec AG, ZEISS Group, Santen Pharmaceutical Co. Ltd., Santen Inc., Topcon Corporation, Lumenis Ltd., Alimera Science, Ocular Therapeutix Inc., Acucela Inc., Ampio Pharmaceuticals, Kowa Company Ltd., Nidek Co. Ltd.
What Are the Latest Innovations in the Non-Proliferative Diabetic Retinopathy Market?
Leading firms in the non-proliferative diabetic retinopathy market are harnessing the potential of AI-integrated cameras to enhance patient results and progress in ophthalmic imaging. These unique cameras fitted with AI technology aid in capturing, assessing, and understanding eye imagery for diagnosis and treatment. In May 2024, Optomed, a medical technology firm based in Finland, introduced the Optomed Aurora AEYE, a handheld AI-based fundus camera, capable of detecting more than basic diabetic retinopathy instantly. This innovative tool merges the convenience of a portable camera and the capabilities of AI to deliver high-resolution retinal images for the early detection and tracking of different eye diseases. The Optomed Aurora AEYE applies AI algorithms to aid healthcare providers in analyzing retinal images, enabling them to diagnose conditions like diabetic retinopathy, glaucoma, and age-based macular degeneration swiftly and precisely.
How Is the Non-Proliferative Diabetic Retinopathy Market Segmented?
The non-proliferative diabetic retinopathy market covered in this report is segmented -
1) By Treatment Type: Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy
2) By Disease Severity Level: Mild Non-Proliferative Diabetic Retinopathy, Moderate Non-Proliferative Diabetic Retinopathy, Severe Non-Proliferative Diabetic Retinopathy
3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Anti-Vascular Endothelial Growth Factor (Vegf) Therapy: Bevacizumab (Avastin), Ranibizumab (Lucentis), Aflibercept (Eylea), Pegaptanib (Macugen)
2) By Intraocular Steroid Injection: Triamcinolone Acetonide, Dexamethasone Implant (Ozurdex), Fluocinolone Acetonide Implant (Iluvien)
3) By Laser Surgery: Focal Laser Photocoagulation, Panretinal Photocoagulation
4) By Vitrectomy: Pars Plana Vitrectomy (Ppv), Membrane Peeling Vitrectomy, Phaco-Vitrectomy (Combined Cataract And Vitrectomy Surgery)
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/non-proliferative-diabetic-retinopathy-global-market-report
Where Is the Non-Proliferative Diabetic Retinopathy Market Growth Most Prominent?
North America was the largest region in the non-proliferative diabetic retinopathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-proliferative diabetic retinopathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Non-Proliferative Diabetic Retinopathy Global Market Report?
- Market Size Analysis: Analyze the Non-Proliferative Diabetic Retinopathy Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Non-Proliferative Diabetic Retinopathy Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Non-Proliferative Diabetic Retinopathy Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Non-Proliferative Diabetic Retinopathy Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15620
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Influencer in the Non-Proliferative Diabetic Retinopathy Market 2025: Surging Prevalence Of Diabetes Fuels Growth In The Non-Proliferative Diabetic Retinopathy Market Driver here
News-ID: 3864368 • Views: …
More Releases from The Business Research Company
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth?
In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025?
In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,…
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025?
The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate…
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025?
The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.…
More Releases for Diabetic
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Leading Element Driving Change in the Diabetic Footwear Market in 2025: Rising D …
Which drivers are expected to have the greatest impact on the over the diabetic footwear market's growth?
The surge in people with diabetes will spur the expansion of the diabetic footwear market in the future. Diabetes, characterised by high blood sugar levels, is a long-term health issue. Diabetic footwear can prevent severe foot-related issues caused by diabetes and offer several advantages such as enhanced blood flow, ample space for the toes,…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
